Summary
This 8-K filing from Edwards Lifesciences (EW) on April 20, 2010, announces the company's financial results for the first quarter of 2010 via a press release, which is included as an exhibit. The report itself does not contain detailed financial figures but serves as a notification of the release of this information to the public. Investors should refer to the attached press release (Exhibit 99.1) for specific details regarding Edwards Lifesciences' performance in Q1 2010. This includes key financial metrics, operational updates, and potentially forward-looking statements that would be crucial for assessing the company's current financial health and future prospects. The filing indicates that the CFO, Thomas M. Abate, has signed off on the report.
Key Highlights
- 1Edwards Lifesciences (EW) filed an 8-K report on April 20, 2010.
- 2The primary purpose of the filing is to announce the company's first-quarter 2010 financial results.
- 3The detailed financial results are provided in an attached press release, Exhibit 99.1.
- 4This filing serves as a notification that the Q1 2010 earnings information is now publicly available.
- 5The report is furnished under Item 2.02 (Results of Operations and Financial Condition).
- 6The Chief Financial Officer, Thomas M. Abate, signed the report.
- 7Information furnished under Item 2.02 is not deemed 'filed' for purposes of the Securities Exchange Act of 1934.